Ruchi Gupta is a seasoned leader in drug development with 16 years of experience, currently serving as the Head of Biomarker Development & Operations at Alector. They have held prominent positions at Gilead Sciences and Johnson & Johnson, specializing in areas such as neuroimmunology, liver diseases, and cardiovascular conditions. Ruchi earned a PhD in Chemistry from Stony Brook University and has contributed to the field through research in various therapeutic areas, notably diabetes and Alzheimer’s disease. They have received multiple awards for their leadership and innovation, including the Women of Power award in 2022, and actively participate as a board member for Women in Neuroscience, showcasing their commitment to scientific integrity and collaboration.
This person is not in the org chart
This person is not in any teams
This person is not in any offices